Target intelligence / Profile preview

5S ribosomal RNA pseudogene 214 (RNA5SP214)

Target
RNA5SP214
Molecular classification
Pseudogene, Non-coding RNA, rRNA pseudogene
01

Overview

5S ribosomal RNA pseudogene 214 is a processed non-coding pseudogene derived from the 5S ribosomal RNA gene family but accumulated mutations that rendered it non-functional. 5S rRNA itself is an essential structural and functional RNA component of the large ribosomal subunit in all domains of life (except animal/yeast mitochondria), critical for ribosome structure, assembly, and protein synthesis[1][3]. Pseudogenes like RNA5SP214 typically result from duplication events and subsequent mutational decay, often identified by high sequence similarity to functional genes, but lacking expression, introns, and protein-coding capability[2][4][6]. This pseudogene does not participate in ribosome activity, cellular regulation, or as a drug target. It is classified among rRNA pseudogenes and may be annotated in genomic datasets but lacks clinical or biochemical significance. While some pseudogenes are occasionally transcribed and may mildly influence gene regulation epigenetically or via RNA interference, there is no evidence for this specific pseudogene having such activity[6]. Key Point: RNA, 5S ribosomal pseudogene 214 refers to a non-coding, non-functional RNA gene remnant; it should not be considered a therapeutic target, receptor, enzyme, transporter, or biomarker by current standards[4][6].

Other names
RN5S214RNA5SP214RNA, 5S ribosomal 214
02

Mechanism of action

None (no drug-target mechanism; pseudogene does not produce a functional product)

03

Biological functions

Other (no known functional role; pseudogenes generally lack biological function but may occasionally act as regulatory non-coding RNAs in rare cases[6])
04

Disease associations

Other (no known direct role; pseudogenes sometimes implicated in regulatory events or as sources of endogenous siRNAs, but evidence for disease connection is rare and not established for this specific pseudogene[6])
05

Safety considerations

None (therapeutic targeting is not relevant; pseudogene)
06

Interacting drugs

None (pseudogenes generally do not encode proteins or functional RNAs that interact with drugs)
07

Biomarkers

None (not used as biomarker; unlike functional ribosomal RNA genes, pseudogenes lack robust expression or function[6])

Beyond the preview

Go deeper on 5S ribosomal RNA pseudogene 214 (RNA5SP214).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5S ribosomal RNA pseudogene 214 (RNA5SP214).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call